logo

For the Inventor, By the Inventor

Bottmingen, Switzerland

Franz Troxler

USPTO Granted Patents = 12

Average Co-Inventor Count = 1.8

ph-index = 5

Forward Citations = 68(Granted Patents)


Company Filing History:

goldMedal12 out of 1,603 
 
Sandoz Gmbh
 patents

Years Active: 1977-1986

Loading Chart...
12 patents (USPTO):Explore Patents
1. 4609657 - Ergot peptide alkaloid derivatives, processes for their preparation and (1986-09-02),
2. 4434176 - Use of 4-(2-benzoyloxy-3-tert-butylaminopropoxy)-2-methyl-indole for (1984-02-28),
3. 4350634 - N-Benzoyl-N'-3-indolyl-N'alkyl-1,3-diaminopropanes (1982-09-21),
4. 4340541 - 4-(2-Benzoyloxy-3-tert.-butylaminopropoxy-2-methyl indole (1982-07-20),
5. 4165374 - Thieno[3,2-c]pyridines (1979-08-21),
6. 4137331 - 3-Piperidino-2-hydroxypropoxy substituted-2-indolinones (1979-01-30),
7. 4124719 - -4-Phenylhexahydro-4-indolinol derivatives (1978-11-07),
8. 4080463 - 2-Substituted-aminopropoxy indoles (1978-03-21),
9. 4073909 - Isoquinoline compounds (1978-02-14),
10. 4071630 - 1-Substituted-amino-3-(4-furo[3,2-c]pyridinyloxy)-2-propanols (1978-01-31),
11. 4067873 - Certain 1-amino-3-(1-isoquinolinyl)oxy-2-propanol derivatives (1978-01-10),
12. 4057560 - 1,2,2A,3,4,5 Hexahydrobenz[c,d]indol-1-yl-2-guanidines (1977-11-08),

Title: Franz Troxler: Innovator in Pharmaceutical Chemistry

Introduction

Franz Troxler is a notable inventor based in Bottmingen, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 12 patents to his name, Troxler's work has had a considerable impact on the industry.

Latest Patents

Among his latest patents, Troxler has developed ergot peptide alkaloid derivatives and processes for their preparation. This invention provides compounds that promote prolactin secretion, showcasing his innovative approach to pharmaceutical development. Another notable patent involves the use of 4-(2-benzoyloxy-3-tert-butylaminopropoxy)-2-methyl-indole, which includes compounds with specific structural characteristics aimed at enhancing therapeutic efficacy.

Career Highlights

Franz Troxler has built a successful career at Sandoz GmbH, where he has been instrumental in advancing research and development initiatives. His expertise in creating new chemical entities has positioned him as a key player in the pharmaceutical sector.

Collaborations

Throughout his career, Troxler has collaborated with esteemed colleagues such as Erik Wiskott and Fritz Seemann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Franz Troxler's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the development of new therapeutic agents, underscoring the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…